The company has informed NICE that it will not provide an evidence submission for this appraisal. Therefore, we are suspending the appraisal while we consider the next steps.
| Status | Suspended |
| Technology type | Medicine |
| Decision | Selected |
| Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
| Process | STA Standard |
| ID number | 6143 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 01 September 2023 | Suspended. The company has informed NICE that it will not provide an evidence submission for this appraisal. Therefore, we are suspending the appraisal while we consider the next steps. |
| 19 July 2023 - 10 August 2023 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6143 |
| 10 August 2023 | The National Institute for Health and Care Excellence (NICE) has been asked to conduct an appraisal of baricitinib for treating juvenile idiopathic arthritis in children and young people aged 1 to 17 ID6143. We have recently invited stakeholders to respond to a written consultation on the draft scope for this evaluation. The company that market baricitinib have informed NICE that it will not provide an evidence submission for the evaluation. In light of this information NICE will suspend this evaluation from its current work programme, this means the consultation on the draft scope will now close. Please accept our apologies for any inconvenience. As this evaluation has been referred to NICE, we will continue to monitor any development and will update interested parties if the situation changes. If you have any comments or concerns, please contact the project manager for this proposed appraisal Emily Richards on emily.richards@nice.org.uk |
| 13 October 2022 | In progress. DHSC referral received |
| 15 June 2022 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual